Platelet-rich plasma versus steroids injections for greater trochanter pain syndrome: A systematic review and meta-analysis

15Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: Greater trochanter pain syndrome (GTPS) is characterized by a persistent and debilitating pain around the greater trochanter. GTPS can be caused by a combination of gluteus medius or minimus tendinopathy, snapping hip or trochanteric bursitis. Source of data: Recent published literatures identified from PubMed, EMBASE, Google Scholar, Scopus. Areas of agreement: Platelet rich plasma (PRP) and corticosteroids (CCS) injections are useful options to manage symptoms of GTPS. Areas of controversy: Whether PRP leads to superior outcomes compared to CCS injections is unclear. Growing points: A systematic review and meta-analysis comparing PRP versus CCS in the management of GTPS was conducted. Areas timely for developing research: PRP injections are more effective than CCS at approximately 2 years follow-up.

Cite

CITATION STYLE

APA

Migliorini, F., Kader, N., Eschweiler, J., Tingart, M., & Maffulli, N. (2021, September 1). Platelet-rich plasma versus steroids injections for greater trochanter pain syndrome: A systematic review and meta-analysis. British Medical Bulletin. Oxford University Press. https://doi.org/10.1093/bmb/ldab018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free